Press release
Cancer Biomarkers Market: Growth, Trends, and Key Insights for 2025 | Top prominent players - QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc.
Cancer Biomarkers Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cancer-biomarkers-market?sz
The Global Cancer Biomarker Market reached USD 13.2 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 32.5 billion by 2031. The global cancer biomarker market is expected to exhibit a CAGR of 12.3% during the forecast period (2024-2031).
The Cancer Biomarkers Market involves the use of specific biological indicators to detect, diagnose, and monitor cancer. These biomarkers can be proteins, genes, or other molecules that signal the presence or progression of cancer. They are crucial for personalized medicine, helping to tailor treatments based on individual cancer profiles, thus improving outcomes and reducing side effects.
Competitive Evaluation:
Companies covered in this report are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, bioMérieux SA, Enzo Biochem, Inc., Merck Millipore, Micron Technology, among Others.
The Cancer Biomarkers Market analysis identifies a number of major market players. It enables companies to understand the strategies and partnerships used by other industry players to combat market competition. The comprehensive market report provides a fascinating microscopic look at the market. Corporations can detect the footprints of manufacturers by learning about demand, the global price of manufacturers, and the global benefit of manufacturing companies.
Key Development
On April 25, 2023, Guardant Health, Inc., a leader in precision oncology, and the Parker Institute for Cancer Immunotherapy (PICI), renowned for its expertise in immuno-oncology (IO), entered into a research collaboration. This agreement focuses on exploring the relationship between molecular cancer biomarkers and patient responses to immunotherapy treatments across more than 14 cancer types. The partnership aims to enhance understanding of how biomarker-driven approaches can optimize immunotherapy efficacy.
On November 24, 2022, OncoDNA, a precision medicine company specializing in cancer and genetic disease treatments, partnered with Eli Lilly Italia to enhance access to biomarker testing for thyroid cancer patients in Italy. This collaboration aims to support personalized treatment selection, ensuring patients receive the most effective therapies based on their unique genetic profiles.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/cancer-biomarkers-market
Cancer Biomarkers Market Segments
The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.
By Cancer Indication: Sarcoma, Colorectal Cancer, Cervical Cancer, Lung Cancer, Breast Cancer.
By Biomarker Type: PSA, HER-2, EGFR, KRAS, Others.
By Profiling Technology: Omics Technologies, Cytogenetics, Immunoassays, Imaging Technologies, Bioinformatics.
By End User: Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories.
Regional Assessment:
Regional analysis includes segmentation based on the geography that accentuates the recent and future demand for Cancer Biomarkers market across North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also focuses on the demand for each application segment over all the prominent regions.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
In terms of geographical analysis, Cancer Biomarkers Market report provides an in-depth view of:-
∎ Regional level break-up
∎ Leading growth rates
∎ Countries with the largest market share
∎ Market factors
∎ Latest developments
∎ Industry challenges
∎ Regulatory policies
∎ Player strategies
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-biomarkers-market
This report provides a 360-degree synopsis of the competitive scenario of the Cancer Biomarkers industry. It has enormous awareness joined to the ongoing item and technical improvements in the business sector. It has a thorough analysis of the impact of the potential future development of these headways, a wide-ranging review of those extensions available for future growth.
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Browse More Reports: https://www.datamintelligence.com/research-report/cancer-biomarkers-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market: Growth, Trends, and Key Insights for 2025 | Top prominent players - QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc. here
News-ID: 3988329 • Views: …
More Releases from DataM Intelligence 4Market Research
Drug Delivery Infusion System Market to Hit USD 22.62 Billion by 2033, Report by …
Overview of the Market:
The Global Drug Delivery Infusion System Market is experiencing steady growth, driven by the rising demand for advanced healthcare solutions that ensure accurate and controlled medication administration. Infusion systems have become a cornerstone in modern medical treatments, particularly in oncology, pain management, diabetes care, and critical care, where precision dosing is essential. These systems improve patient outcomes, reduce dosing errors, and enable continuous drug delivery, which is…
Arthroscopy Devices Market to Grow at 9% CAGR Through 2031, Says DataM Intellige …
Overview of the Market
The Arthroscopy Devices Market is experiencing robust growth, driven by the rising incidence of sports-related injuries, orthopedic disorders, and the global shift toward minimally invasive surgical procedures. Arthroscopy is a surgical technique that allows doctors to diagnose and treat joint problems using small incisions, specialized instruments, and a camera system. Its advantages include reduced recovery time, lower risks of complications, and improved patient outcomes, which have made…
Active Pharmaceutical Ingredients Market to Witness Substantial Growth, Hitting …
Overview of the Market
The Active Pharmaceutical Ingredients (API) Market represents one of the most critical pillars of the pharmaceutical value chain, driving innovation, availability, and affordability of medicines globally. APIs are the biologically active components in drugs that produce the intended therapeutic effect, and their demand continues to rise in tandem with the growth of the pharmaceutical sector. According to DataM Intelligence, The Global Active Pharmaceutical Ingredients Market was valued…
Prostate Cancer Market to Achieve USD 21.6 Billion by 2032, According to DataM I …
Overview of the Market:
The Prostate Cancer Market has been experiencing substantial growth in recent years, driven by rising incidence rates, improved diagnostic technologies, and a surge in awareness regarding early detection and treatment options. Prostate cancer is one of the most common cancers among men, particularly in developed countries, and its prevalence has prompted significant investments in pharmaceuticals, diagnostics, and treatment modalities. Increasing adoption of targeted therapies, advancements in radiotherapy,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
